These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9400993)

  • 21. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.
    Gasco M; Bell AK; Heath V; Sullivan A; Smith P; Hiller L; Yulug I; Numico G; Merlano M; Farrell PJ; Tavassoli M; Gusterson B; Crook T
    Cancer Res; 2002 Apr; 62(7):2072-6. PubMed ID: 11929827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
    Nemes JA; Deli L; Nemes Z; Márton IJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma.
    Kusama K; Okutsu S; Takeda A; Himiya T; Kojima A; Kidokoro Y; Chu L; Iwanari S; Kudo I; Moro I
    J Pathol; 1996 Apr; 178(4):415-21. PubMed ID: 8691320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
    Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
    Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
    Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
    J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
    Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infrequent p53 mutations in arsenic-related skin lesions.
    Castrén K; Ranki A; Welsh JA; Vähäkangas KH
    Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
    Ries JC; Schreiner D; Steininger H; Girod SC
    Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
    Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
    Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 gene mutations in human urothelial carcinomas: analysis by immunohistochemistry and single-strand conformation polymorphism.
    Oyasu R; Nan L; Szumel RC; Kawamata H; Hirohashi S
    Mod Pathol; 1995 Feb; 8(2):170-6. PubMed ID: 7777479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
    Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V
    J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P53-mutation in smears of oral squamous cell carcinoma.
    Friedrich RE; Giese M; Riethdorf S; Loning T
    Anticancer Res; 2000; 20(6D):4927-30. PubMed ID: 11326641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoma of the vulva: HPV and p53 mutations.
    Lee YY; Wilczynski SP; Chumakov A; Chih D; Koeffler HP
    Oncogene; 1994 Jun; 9(6):1655-9. PubMed ID: 8183560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas.
    Oliveira MC; Soares RC; Pinto LP; Souza LB; Medeiros SR; Costa Ade L
    Auris Nasus Larynx; 2009 Aug; 36(4):450-6. PubMed ID: 19124208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
    Zhang J; Zheng J; Fang W
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
    Fukuda M; Nakatsuka T; Kusama K; Sakashita H
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.